These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15070701)

  • 1. Regulation of annexin II by cytokine-initiated signaling pathways and E2A-HLF oncoprotein.
    Matsunaga T; Inaba T; Matsui H; Okuya M; Miyajima A; Inukai T; Funabiki T; Endo M; Look AT; Kurosawa H
    Blood; 2004 Apr; 103(8):3185-91. PubMed ID: 15070701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E4BP4 expression is regulated by the t(17;19)-associated oncoprotein E2A-HLF in pro-B cells.
    Yeung J; O'Sullivan E; Hubank M; Brady HJ
    Br J Haematol; 2004 Jun; 125(5):560-7. PubMed ID: 15147370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of survivin by the E2A-HLF chimera is indispensable for the survival of t(17;19)-positive leukemia cells.
    Okuya M; Kurosawa H; Kikuchi J; Furukawa Y; Matsui H; Aki D; Matsunaga T; Inukai T; Goto H; Altura RA; Sugita K; Arisaka O; Look AT; Inaba T
    J Biol Chem; 2010 Jan; 285(3):1850-60. PubMed ID: 19887369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptors.
    Zhang X; Inukai T; Hirose K; Akahane K; Kuroda I; Honna-Oshiro H; Kagami K; Goi K; Nakamura K; Kobayashi M; Endo M; Yagita H; Kurosawa H; Thomas Look A; Honda H; Inaba T; Nakazawa S; Sugita K
    Leukemia; 2012 Dec; 26(12):2483-93. PubMed ID: 22743623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-binding specificity and trans-activating potential of the leukemia-associated E2A-hepatic leukemia factor fusion protein.
    Inaba T; Shapiro LH; Funabiki T; Sinclair AE; Jones BG; Ashmun RA; Look AT
    Mol Cell Biol; 1994 May; 14(5):3403-13. PubMed ID: 8164688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABCB1 over-expression and drug-efflux in acute lymphoblastic leukemia cell lines with t(17;19) and E2A-HLF expression.
    Baudis M; Prima V; Tung YH; Hunger SP
    Pediatr Blood Cancer; 2006 Nov; 47(6):757-64. PubMed ID: 16206189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19).
    Hirose K; Inukai T; Kikuchi J; Furukawa Y; Ikawa T; Kawamoto H; Oram SH; Göttgens B; Kiyokawa N; Miyagawa Y; Okita H; Akahane K; Zhang X; Kuroda I; Honna H; Kagami K; Goi K; Kurosawa H; Look AT; Matsui H; Inaba T; Sugita K
    Blood; 2010 Aug; 116(6):962-70. PubMed ID: 20519628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-binding and transcriptional regulatory properties of hepatic leukemia factor (HLF) and the t(17;19) acute lymphoblastic leukemia chimera E2A-HLF.
    Hunger SP; Brown R; Cleary ML
    Mol Cell Biol; 1994 Sep; 14(9):5986-96. PubMed ID: 8065331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The proto-oncogene HLF and the related basic leucine zipper protein TEF display highly similar DNA-binding and transcriptional regulatory properties.
    Hunger SP; Li S; Fall MZ; Naumovski L; Cleary ML
    Blood; 1996 Jun; 87(11):4607-17. PubMed ID: 8639829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two candidate downstream target genes for E2A-HLF.
    Kurosawa H; Goi K; Inukai T; Inaba T; Chang KS; Shinjyo T; Rakestraw KM; Naeve CW; Look AT
    Blood; 1999 Jan; 93(1):321-32. PubMed ID: 9864177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2A/HLF fusion cDNAs and the use of RT-PCR for the detection of minimal residual disease in t(17;19)(q22;p13) acute lymphoblastic leukemia.
    Devaraj PE; Foroni L; Sekhar M; Butler T; Wright F; Mehta A; Samson D; Prentice HG; Hoffbrand AV; Secker-Walker LM
    Leukemia; 1994 Jul; 8(7):1131-8. PubMed ID: 7518549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The E2A-HLF oncoprotein activates Groucho-related genes and suppresses Runx1.
    Dang J; Inukai T; Kurosawa H; Goi K; Inaba T; Lenny NT; Downing JR; Stifani S; Look AT
    Mol Cell Biol; 2001 Sep; 21(17):5935-45. PubMed ID: 11486032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The AD1 and AD2 transactivation domains of E2A are essential for the antiapoptotic activity of the chimeric oncoprotein E2A-HLF.
    Inukai T; Inaba T; Ikushima S; Look AT
    Mol Cell Biol; 1998 Oct; 18(10):6035-43. PubMed ID: 9742120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2A/HLF fusion gene in an acute lymphoblastic leukemia patient with disseminated intravascular coagulation and a normal karyotype.
    Dahéron L; Brizard F; Millot F; Cividin M; Lacotte L; Guilhot F; Brizard A
    Hematol J; 2002; 3(3):153-6. PubMed ID: 12111652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the t(17;19) translocation by gene-specific fluorescent in situ hybridization-based cytogenetics and detection of the E2A-HLF fusion transcript and protein in patients' cells.
    Yeung J; Kempski H; Neat M; Bailey S; Smith O; Brady HJ
    Haematologica; 2006 Mar; 91(3):422-4. PubMed ID: 16531271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia.
    Hunger SP; Ohyashiki K; Toyama K; Cleary ML
    Genes Dev; 1992 Sep; 6(9):1608-20. PubMed ID: 1516826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chimeric E2A-HLF transcription factor abrogates p53-induced apoptosis in myeloid leukemia cells.
    Altura RA; Inukai T; Ashmun RA; Zambetti GP; Roussel MF; Look AT
    Blood; 1998 Aug; 92(4):1397-405. PubMed ID: 9694729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2A-HLF chimeric transcription factors in pro-B cell acute lymphoblastic leukemia.
    Look AT
    Curr Top Microbiol Immunol; 1997; 220():45-53. PubMed ID: 9103674
    [No Abstract]   [Full Text] [Related]  

  • 19. Reversal of apoptosis by the leukaemia-associated E2A-HLF chimaeric transcription factor.
    Inaba T; Inukai T; Yoshihara T; Seyschab H; Ashmun RA; Canman CE; Laken SJ; Kastan MB; Look AT
    Nature; 1996 Aug; 382(6591):541-4. PubMed ID: 8700228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two types of genomic rearrangements create alternative E2A-HLF fusion proteins in t(17;19)-ALL.
    Hunger SP; Devaraj PE; Foroni L; Secker-Walker LM; Cleary ML
    Blood; 1994 May; 83(10):2970-7. PubMed ID: 8180393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.